Published in J Clin Microbiol on February 07, 2007
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Global distribution and prevalence of hepatitis C virus genotypes. Hepatology (2014) 3.95
Genetic history of hepatitis C virus in East Asia. J Virol (2008) 2.20
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol (2008) 1.49
Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One (2008) 1.43
HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology (2012) 1.30
Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol (2009) 1.24
Ever closer to a prophylactic vaccine for HCV. Expert Opin Biol Ther (2013) 1.15
Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia. Saudi J Gastroenterol (2013) 1.02
Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. J Virol (2012) 1.02
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol (2014) 1.02
Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One (2012) 1.01
Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses. Virol J (2008) 0.99
HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate. PLoS One (2012) 0.97
Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0. J Clin Microbiol (2013) 0.96
Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants. J Infect Dis (2012) 0.94
Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. J Virol (2011) 0.94
Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China. PLoS One (2013) 0.93
Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6. J Gen Virol (2012) 0.92
Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa. Virology (2014) 0.92
Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns. J Gen Virol (2012) 0.92
The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis. PLoS One (2015) 0.90
Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein. J Virol (2013) 0.90
Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol (2013) 0.90
Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One (2012) 0.89
Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol (2015) 0.89
Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t. J Gen Virol (2009) 0.89
Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevir. PLoS One (2012) 0.89
Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region. PLoS One (2010) 0.88
Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. Can J Infect Dis Med Microbiol (2007) 0.88
Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping. Int J Mol Epidemiol Genet (2010) 0.88
Epidemiology and treatment of hepatitis C genotypes 5 and 6. Can J Gastroenterol (2013) 0.87
Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One (2015) 0.87
The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology (2014) 0.87
Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant. J Gen Virol (2012) 0.87
Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol (2014) 0.87
Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus. J Clin Microbiol (2015) 0.87
Signatures of protective memory immune responses during hepatitis C virus reinfection. Gastroenterology (2014) 0.86
A method for near full-length amplification and sequencing for six hepatitis C virus genotypes. BMC Genomics (2016) 0.86
Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol (2014) 0.86
Genetic history of hepatitis C virus in Venezuela: high diversity and long time of evolution of HCV genotype 2. PLoS One (2010) 0.86
Update on hepatitis B and C virus diagnosis. World J Virol (2015) 0.85
Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6. J Clin Microbiol (2014) 0.85
Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence. J Clin Microbiol (2010) 0.84
Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J Gastroenterol (2014) 0.84
Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol (2014) 0.84
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol (2016) 0.84
Hepatitis C virus: A global view. World J Hepatol (2015) 0.83
A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame. J Med Virol (2008) 0.83
Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One (2013) 0.83
Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection. J Immunol Res (2015) 0.82
Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimens. J Clin Microbiol (2012) 0.82
Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review. World J Virol (2015) 0.82
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district. Clinicoecon Outcomes Res (2016) 0.81
Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form. Int J Mol Sci (2016) 0.81
Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing. J Clin Microbiol (2015) 0.81
Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol (2013) 0.81
Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections. Front Microbiol (2014) 0.80
Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol (2016) 0.80
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol (2015) 0.79
Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA. J Clin Microbiol (2012) 0.79
Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol (2015) 0.78
Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia. Genome Announc (2013) 0.78
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina. World J Gastroenterol (2013) 0.78
Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal. PLoS One (2015) 0.77
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin. Medicine (Baltimore) (2015) 0.77
Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep (2015) 0.77
Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol (2014) 0.77
Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc. Virology (2014) 0.77
Analysis of HCV quasispecies dynamic under selective pressure of combined therapy. BMC Infect Dis (2013) 0.77
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations. PLoS One (2014) 0.77
The Strange, Expanding World of Animal Hepaciviruses. Annu Rev Virol (2016) 0.76
Influence of hepatitis C virus and IL28B genotypes on liver stiffness. PLoS One (2014) 0.76
An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes. Virology (2015) 0.76
Evolving Diversity of Hepatitis C Viruses in Yunnan Honghe, China. Int J Mol Sci (2016) 0.76
Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Res Notes (2011) 0.76
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt. Hepat Mon (2013) 0.76
Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China. PLoS One (2014) 0.76
Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review. Hepat Mon (2016) 0.75
Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay. Int J Mol Sci (2016) 0.75
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution. Virol J (2017) 0.75
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men. PLoS One (2016) 0.75
The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages. Virology (2015) 0.75
Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy. J Transl Med (2014) 0.75
The evolutionary patterns of hepatitis C virus subtype 2a and 6a isolates linked to an outbreak in China in 2012. Virology (2015) 0.75
A Single-step Multiplex Quantitative Real Time Polymerase Chain Reaction Assay for Hepatitis C Virus Genotypes. J Transl Int Med (2017) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16
Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res (1998) 96.63
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics (2002) 19.27
Global epidemiology of hepatitis C virus infection. Lancet Infect Dis (2005) 16.44
The Staden package, 1998. Methods Mol Biol (2000) 11.30
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53
Unravelling hepatitis C virus replication from genome to function. Nature (2005) 5.25
The Los Alamos hepatitis C sequence database. Bioinformatics (2004) 3.67
Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol (1996) 3.22
A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol (2002) 3.20
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med (2004) 2.29
Use and interpretation of virological tests for hepatitis C. Hepatology (2002) 1.92
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol (2006) 1.90
Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol (1999) 1.80
Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol (2002) 1.78
Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol (2004) 1.69
Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol (2003) 1.67
Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol (2003) 1.62
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol (2005) 1.57
Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol (1995) 1.46
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol (2005) 1.45
Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol (1996) 1.41
Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol (2003) 1.39
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C. Hepatology (2005) 1.38
Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol (2006) 1.33
Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods (2003) 1.32
Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol (1995) 1.29
Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model. J Infect Dis (2005) 1.26
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat (2002) 1.25
Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region. J Clin Microbiol (1997) 1.25
Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol (2003) 1.24
A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol (2006) 1.21
Genomic and phylogenetic analysis of hepatitis C virus isolates: a survey of 535 strains circulating in southern France. J Med Virol (2003) 1.16
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol (1996) 1.14
Hepatitis C databases, principles and utility to researchers. Hepatology (2006) 1.13
High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol (2003) 1.06
Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol (2005) 1.05
Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol (1996) 1.04
Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg (2005) 0.99
Hepatitis C virus genotyping: clinical implications and methods. Mol Diagn (2001) 0.96
Evolution of hepatitis C virus in blood donors and their respective recipients. J Gen Virol (2003) 0.88
High-throughput DNA sequencing: a genomic data manufacturing process. DNA Seq (1999) 0.79
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology (2006) 3.92
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology (2004) 2.44
Management of chronic hepatitis C: consensus guidelines. Can J Gastroenterol (2007) 2.06
[Time to think in new ways? Frequent suicide risk assessments can increase the danger of suicide]. Lakartidningen (2010) 2.01
Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol (2008) 1.90
Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol (2007) 1.78
Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology (2003) 1.48
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology (2007) 1.22
Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion (2008) 1.11
Villous adenoma of the common bile duct transforming into a cholangiocarcinoma. Isr Med Assoc J (2002) 1.01
Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol (2010) 1.01
Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol (2007) 1.00
Pretransplantation α-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation (2013) 0.99
Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl (2005) 0.98
Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol (2010) 0.97
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol (2007) 0.97
Intramucosal esophageal dissection leading to esophageal perforation: case report and review of the literature. Gastroenterol Hepatol (N Y) (2008) 0.95
Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci (2002) 0.94
Inflammation and repair in viral hepatitis C. Dig Dis Sci (2008) 0.94
Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol (2008) 0.93
Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol (2012) 0.93
Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation. Transplantation (2011) 0.91
Comparison of a real-time polymerase chain reaction assay for lactase genetic polymorphism with standard indirect tests for lactose maldigestion. Clin Gastroenterol Hepatol (2006) 0.90
Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. Can J Infect Dis Med Microbiol (2007) 0.88
Epidemiology and treatment of hepatitis C genotypes 5 and 6. Can J Gastroenterol (2013) 0.87
Altered thymic function during interferon therapy in HCV-infected patients. PLoS One (2012) 0.82
Evaluating cimetidine for GFR estimation in liver transplant recipients. Nephrol Dial Transplant (2009) 0.82
The effect of information level and coping style on pain and anxiety in needle liver biopsy. Can J Gastroenterol (2006) 0.82
Clinical manifestations of portal hypertension. Int J Hepatol (2012) 0.81
Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance. Hepatol Int (2011) 0.80
IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test. Immunogenetics (2013) 0.80
The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease. Can J Gastroenterol (2012) 0.79
Care of the liver transplant patient. Can J Gastroenterol Hepatol (2014) 0.77
Multiple factors involved in nonalcoholic hepatitis pathogenesis. Int J Hepatol (2012) 0.76
Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection. Liver Int (2009) 0.76
Early onset, nefazodone-induced fulminant hepatic failure. Am J Gastroenterol (2003) 0.76
Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum. Can J Gastroenterol (2012) 0.75
Prevalence and predictors of sleep disturbance among liver diseases in long-term transplant survivors. Can J Gastroenterol Hepatol (2015) 0.75
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop. Can J Gastroenterol (2006) 0.75
Successful liver transplantation using the liver of donors with cystic fibrosis. Hepatology (2003) 0.75
Chylous ascites secondary to giant liver hemangioma. Case Rep Gastroenterol (2012) 0.75
Relapsing polychondritis and ulcerative colitis. Saudi J Gastroenterol (2010) 0.75
Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy. Can J Gastroenterol Hepatol (2013) 0.75
Review. Gastroenterol Hepatol (N Y) (2007) 0.75
Erratum to: IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test. Immunogenetics (2015) 0.75
Calibration and statistical analysis of a simplified model for the anaerobic digestion of solid waste. Environ Technol (2009) 0.75
Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response. J Med Virol (2004) 0.75
Hemodynamic changes in visceral organs following closed head trauma in rats. Resuscitation (2007) 0.75
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes? Ann Hepatol (2011) 0.75
[Suicide within health care: criticism by the National Board of Health and Welfare is based on theories and wishful thinking]. Lakartidningen (2011) 0.75